These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9511089)

  • 1. Anti-endotoxin therapeutic options for the treatment of sepsis.
    Lynn WA
    J Antimicrob Chemother; 1998 Jan; 41 Suppl A():71-80. PubMed ID: 9511089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
    Opal SM; Yu RL
    Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting endotoxin in the treatment of sepsis.
    Rachoin JS; Schorr CA; Dellinger RP
    Subcell Biochem; 2010; 53():323-38. PubMed ID: 20593274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of gram-negative sepsis in man with anti-endotoxin antibodies: a review.
    Wortel CH; Ziegler EJ; van Deventer SJ
    Prog Clin Biol Res; 1991; 367():161-78. PubMed ID: 1924425
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
    Talan DA
    Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current developments in the field of infection caused by gram-negative microorganisms; passive immunization using anti-endotoxin antibodies].
    van Deventer SJ; ten Cate JW; Appelmelk BJ
    Ned Tijdschr Geneeskd; 1987 Oct; 131(43):1907-10. PubMed ID: 3317073
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin.
    Ziegler EJ; McCutchan JA; Braude AI
    Eur J Cancer (1965); 1979; 15 Suppl():71-6. PubMed ID: 397063
    [No Abstract]   [Full Text] [Related]  

  • 9. Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.
    Spapen HD; Diltoer M; Huyghens LP
    Acta Clin Belg; 1993; 48(1):20-9. PubMed ID: 7684546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-human CD14 monoclonal antibody improves survival following sepsis induced by endotoxin, but not following polymicrobial infection.
    Nakamura M; Takeuchi T; Shirakawa K; Furusako S
    Eur J Pharmacol; 2017 Jul; 806():18-24. PubMed ID: 28322834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin tolerance: a review.
    West MA; Heagy W
    Crit Care Med; 2002 Jan; 30(1 Suppl):S64-73. PubMed ID: 11782563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of human gram-negative bacteremia with antiserum against endotoxin core.
    Ziegler EJ; McCutchan JA; Douglas H; Braude AI
    Trans Assoc Am Physicians; 1981; 94():39-43. PubMed ID: 7046193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunotherapy using the anti-endotoxin antibody HA-1A in patients with sepsis syndrome; good results in relation to treatment with placebo].
    Wortel CH; von der Möhlen MA; van Deventer SJ; Schipper HG; Lorijn RH; ten Cate JW
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):350-4. PubMed ID: 8437633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an anti-endotoxin vaccine for sepsis.
    Cross AS
    Subcell Biochem; 2010; 53():285-302. PubMed ID: 20593272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapies for sepsis: antiendotoxin therapies.
    Manocha S; Feinstein D; Kumar A; Kumar A
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1795-812. PubMed ID: 12457439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.
    White AF; Demchenko AV
    Adv Carbohydr Chem Biochem; 2014; 71():339-89. PubMed ID: 25480508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxins and anti-endotoxins (their relevance to the anaesthetist and the intensive care specialist).
    Brock-Utne JG; Gaffin SL
    Anaesth Intensive Care; 1989 Feb; 17(1):49-55. PubMed ID: 2653093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.